Impaired Glutamatergic Neurotransmission in the Ventromedial Hypothalamus May Contribute to Defective Counterregulation in Recurrently Hypoglycemic Rats
Open Access
- 17 April 2017
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 66 (7) , 1979-1989
Abstract
The objectives of this study were to understand the role of glutamatergic neurotransmission in the ventromedial hypothalamus (VMH) in response to hypoglycemia and to elucidate the effects of recurrent hypoglycemia (RH) on this neurotransmitter. We 1) measured changes in interstitial VMH glutamate levels by using microdialysis and biosensors, 2) identified the receptors that mediate glutamate’s stimulatory effects on the counterregulatory responses, 3) quantified glutamate metabolic enzyme levels in the VMH, 4) examined astrocytic glutamate reuptake mechanisms, and 5) used 1H-[13C]-nuclear magnetic resonance (NMR) spectroscopy to evaluate the effects of RH on neuronal glutamate metabolism. We demonstrated that glutamate acts through kainic acid receptors in the VMH to augment counterregulatory responses. Biosensors showed that the normal transient rise in glutamate levels in response to hypoglycemia is absent in RH animals. More importantly, RH reduced extracellular glutamate concentrations partly as a result of decreased glutaminase expression. Decreased glutamate was also associated with reduced astrocytic glutamate transport in the VMH. NMR analysis revealed a decrease in [4-13C]glutamate but unaltered [4-13C]glutamine concentrations in the VMH of RH animals. The data suggest that glutamate release is important for proper activation of the counterregulatory response to hypoglycemia and that impairment of glutamate metabolic and resynthetic pathways with RH may contribute to counterregulatory failure.Keywords
Funding Information
- American Diabetes Association (7-11-BS-21)
- JDRF (2-2008-480)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-099315, DK-45735)
- National Institute of Mental Health (R01-MH-095104)
- National Institute of Neurological Disorders and Stroke (P30-NS-052519)
This publication has 36 references indexed in Scilit:
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter MetabolismBiological Psychiatry, 2012
- Increased GABAergic Output in the Ventromedial Hypothalamus Contributes to Impaired Hypoglycemic Counterregulation in Diabetic RatsDiabetes, 2011
- Sex differences in the neural circuit that mediates female sexual receptivityFrontiers in Neuroendocrinology, 2011
- Glucose Sensing Neurons in the Ventromedial HypothalamusSensors, 2010
- Hypoglycemia in Type 1 DiabetesDiabetes, 2010
- Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to SchizophreniaNeuropsychopharmacology, 2009
- In situ 3D magnetic resonance metabolic imaging of microwave‐irradiated rodent brain: a new tool for metabolomics researchJournal of Neurochemistry, 2009
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzoleMolecular Psychiatry, 2008
- Synaptic Glutamate Release by Ventromedial Hypothalamic Neurons Is Part of the Neurocircuitry that Prevents HypoglycemiaCell Metabolism, 2007
- Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase.Journal of Histochemistry & Cytochemistry, 1994